Skip to main content
Fig. 2 | Alzheimer's Research & Therapy

Fig. 2

From: Model-based stratification of progression along the Alzheimer disease continuum highlights the centrality of biomarker synergies

Fig. 2

Time-series clustering of MMSE scores reveals varying rates of progression in subjects along the AD continuum. A Dendrogram showing the degree of similarity in MMSE time-series taken from individual subjects. B Longitudinal MMSE scores in individuals along the AD continuum over 24 months from baseline clustered into 2 distinct groups: Moderate and Fast Decliners (MD and FD) along with regression lines and 95% confidence intervals. C Variation of CDR-Sum of Boxes scores in the 2 progression phenotypes over 24 months from baseline. D Variation of ADAS Cog13 scores in the same subjects over 24 months from baseline. E Variation of FAQ scores in the same subjects over 24 months from baseline

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193